- Home
- ESS vs SNN Comparison
ESS vs SNN Comparison
Compare ESS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESS | SNN |
|---|---|---|
| Founded | 1971 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 14.3B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | ESS | SNN |
|---|---|---|
| Price | $243.90 | $32.09 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 16 | 2 |
| Target Price | ★ $282.30 | $36.25 |
| AVG Volume (30 Days) | 421.5K | ★ 722.4K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.25% | 2.37% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.40 | N/A |
| Revenue | ★ $1,887,345,000.00 | N/A |
| Revenue This Year | $1.99 | $7.19 |
| Revenue Next Year | $3.39 | $5.36 |
| P/E Ratio | ★ $23.27 | $64.97 |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $238.46 | $23.91 |
| 52 Week High | $307.00 | $38.79 |
Technical Indicators
Market Signals| Indicator | ESS | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 42.48 | 39.27 |
| Support Level | N/A | $29.27 |
| Resistance Level | $263.53 | $33.89 |
| Average True Range (ATR) | 4.77 | 0.48 |
| MACD | -0.31 | -0.05 |
| Stochastic Oscillator | 29.77 | 38.96 |
Price Performance
Historical ComparisonAbout ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 259 apartment communities with over 63,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.